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MHC-independent αβTCRs (TCRs) recognize conformational epitopes on native
self-proteins and arise in mice lacking both MHC and CD4/CD8 coreceptor
proteins. Although naturally generated in the thymus, these TCRs resemble
re-engineered therapeutic chimeric antigen receptor (CAR) T cells in their specificity
for MHC-independent ligands. Here we identify naturally arising MHC-independent
TCRs reactive to three native self-proteins (CD48, CD102, and CD155) involved in
cell adhesion. We report that naturally arising MHC-independent TCRs require high
affinity TCR-ligand engagements in the thymus to signal positive selection and that
high affinity positive selection generates a peripheral TCR repertoire with limited diversity
and increased self-reactivity. We conclude that the affinity of TCR-ligand engagements
required to signal positive selection in the thymus inversely determines the diversity and
self-tolerance of the mature TCR repertoire that is selected.
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INTRODUCTION
The ligand recognition specificity of the αβT cell receptor (TCR) repertoire is established
during T cell differentiation in the thymus. The recombination activating genes Rag1 and Rag2
induce random TCR gene re-arrangements in immature thymocytes and those with productively
rearranged TCRα and TCRβ genes express αβTCR protein complexes on their cell surfaces (1).
These randomly generated surface αβTCR complexes constitute the pre-selection TCR repertoire
and display a huge diversity of potential ligand recognition specificities from which the mature
TCR repertoire is selected in the thymus (2). During thymic selection, many pre-selection TCR
specificities are lost because they fail to engage an intra-thymic ligand and consequently fail to
signal thymocyte survival and maturation. Only immature thymocytes whose TCRs successfully
engage an intra-thymic ligand generate TCR-mediated survival signals and differentiate into
mature T cells, events referred to as positive selection (3, 4).
The mature TCR repertoire that is positively selected in normal mice is specific for linear
antigenic peptides bound to Major Histocompatibility Complex (MHC)-encoded molecules, a
recognition feature known as “MHC restriction” (5–7). In contrast the pre-selection TCR repertoire
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fromwhich themature repertoire is selected includes bothMHC-
restricted TCRs specific for peptide-MHC (pMHC) ligands as
well as MHC-independent TCRs specific for conformational
epitopes on native protein ligands (8). It has been proposed that
the thymus positively selects an MHC-restricted TCR repertoire
because MHC-restricted TCRs engage intra-thymic peptide-
MHC (pMHC) ligands together with CD4/CD8 coreceptors
whose cytosolic tails are associated with p56Lck (Lck) protein
tyrosine kinase molecules that initiate TCR-mediated positive
selection signaling; in contrast, MHC-independent TCRs bind
to intra-thymic protein ligands independently of CD4/CD8
coreceptors and so cannot access coreceptor-associated Lck to
signal positive selection (9). However, in CD4/CD8 coreceptor-
deficient mice, Lck in immature thymocytes is not sequestered
by coreceptors and so is available to transduce signals from
all ligand-engaged TCRs, including TCRs specific for MHC-
independent ligands. Consequently, in coreceptor-deficient
mice that additionally lack MHC [so-called QuadKO mice
(10)], MHC-independent TCRs signal immature thymocytes
to undergo positive selection and to differentiate into mature
T cells expressing only an MHC-independent TCR repertoire.
Thus, unlike the mature TCR repertoire in coreceptor-
expressing mice which is MHC-restricted and specific for pMHC
ligands, the mature TCR repertoire in coreceptor- and MHC-
deficient QuadKO mice is MHC-independent and specific for
conformational epitopes on native protein ligands (9, 11, 12).
Relatively little is known about the specificity and thymic
selection requirements of MHC-independent TCRs because only
two individual TCRs from QuadKO mice (named A11 and
B12A) have been identified and characterized in detail (11, 12).
Curiously, these two TCRs bind to different conformational
epitopes on the same self-protein which is CD155 (the murine
analog of the human polio virus receptor), and they do so
with ∼10-fold higher affinity than that with which conventional
MHC-restricted TCRs bind to foreign antigenic pMHC ligands
(11). Most surprising is that both CD155-specific TCRs require
intra-thymic CD155 to signal positive selection in the thymus
(12) which contrasts starkly with conventionally MHC-restricted
TCRs that only require very low affinity ligand engagements to
signal positive selection (13–15). However, it is not certain if high
affinity ligand engagements are required for positive selection of
otherMHC-independent TCRs or if such a requirement is unique
to the two CD155-specific TCRs A11 and B12A.
We undertook the present study to determine if MHC-
independent TCRs required high affinity TCR-ligand
engagements to signal positive selection and, if so, to determine
the consequences of high affinity thymic selection on the
mature TCR repertoire. We now identify and characterize
MHC-independent TCRs that recognize newMHC-independent
ligands: TCR-38 is specific for CD48 and TCR-146 is specific for
ICAM-2 (CD102). Like CD155, CD48, and CD102 also function
as low affinity ligands for cell adhesion receptors. We focused
on TCR-146 which binds exclusively to ICAM-2 (CD102) and
found that it bound with high 1.6µM affinity independently
of LFA-1. In the thymus, TCR-146 strictly requires ICAM-2
to signal positive selection, indicating that MHC-independent
TCRs generally require high affinity ligand engagements to signal
positive selection which is very different from conventional
MHC-restricted TCRs. Importantly, we discovered that the
requirement for high affinity ligand engagements in the thymus
selects a peripheral MHC-independent TCR repertoire with
markedly limited receptor diversity and increased self-reactivity.
In contrast, dependence on CD4/CD8 coreceptors allows
conventional MHC-restricted TCRs to signal positive selection
with very low affinity ligand engagements which generates
a peripheral TCR repertoire that is both highly diverse and
self-tolerant. We conclude that the affinity of TCR-ligand
engagements that signal positive selection in the thymus
profoundly affects the diversity and self-reactivity of the selected
TCR repertoire.
RESULTS
Identification of Novel MHC-Independent
αβTCRs
The present study was undertaken to enhance understanding
of MHC-independent TCR ligand recognition, positive
selection, and repertoire generation. Because MHC-
independent TCRs are positively selected in QuadKO
(H2-Ab−/−B2m−/−Cd4−/−Cd8−/−) mice, we began by
generating T-hybridoma cell lines from QuadKOBcl-2Tg (QB)
LNT cells that express the pro-survival Bcl-2Tg to minimize loss
of TCR specificities from in vivo signaled cell death (16).
We generated T-hybridomas fromQB LNT cells that had been
stimulated with platebound anti-TCRβ/anti-CD28 antibodies
and screened them for recognition of MHC-independent
ligands expressed on MHCKO antigen presenting cells (APCs)
(Figure 1A). Three T-hybridomas (T-hyb 25, T-hyb 38, and T-
hyb 146) were selected for further study. T-hyb 25 reacted against
MHCKO APC stimulators but not CD155KO APC stimulators,
indicating that itsMHC-independent ligand was CD155, whereas
the other two T-hybridomas (T-hyb 38 and T-hyb 146) reacted
against both MHCKO and CD155KO spleen APC stimulators
indicating that their MHC-independent ligands were molecules
other than CD155 (Figure 1A). TCR sequencing of the selected
T-hybridoma lines revealed that each TCR expressed a single
TCRα and a single TCRβ chain, so that TCR-25 was Vα3
Vβ10 (TRAV9D TRBV4); TCR-38 was Vα1 Vβ16 (TRAV7
TRBV3); and TCR-146 was Vα8 Vβ16 (TRAV12D TRBV3)
(Figure 1B). Complete amino-acid sequences of these TCRs are
displayed in Figure S1.
In vivo Ligand Expression Is Required for
Generation of Ligand-Specific T Cells
Because CD155-specific T-hybridomas appear frequently in
BW5147 fusions with QB LNT cells (11, 12), we could ask if
generation of CD155-specific T cells required in vivo CD155
expression in QB mice. To answer this question, we performed
parallel T-hybridoma fusions with LNT cells from CD155-
sufficient (CD155+/+) and CD155-deficient (CD155−/−)
QB LNT cells (Figure 1C), generating approximately 400
individual T-hybridomas in four independent fusions with
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FIGURE 1 | Reactivity of MHC-independent T-hybridomas from QuadKO mice. (A) Reactivity of T hybridomas 25, 38, and 146 generated from QuadKOBcl2Tg (QB)
mice. T-hybridoma cells (1 × 105) were cocultured with stimulator cells (2 × 105) for 16 hr and assayed for IL-2 production by ELISA. Each point represents the mean
± SEM of triplicate cultures. Data are representative of three independent experiments. (B) Characterization of αβTCRs from T-hybridomas 25, 38, and 146. T-hyb 25
contained Vα3 and Vβ10 TCR chains; T-hyb 38 contained Vα1 and Vβ16 TCR chains; and T-hyb 146 contained Vα8 and Vβ16 TCR chains. (C) CD155-specific T
hybridomas cannot be generated with LNT cells from CD155-deficient mice. Four independent fusions were performed in parallel with LNT cells from QuadKOBcl-2Tg
(QB) and QB. Cd155−/− mice, with each fusion from each strain generating ∼100 T-hybridomas. T-hybridomas reactive to platebound anti-TCR+anti-CD28 mAbs
were then assessed for reactivity against MHCKO and MHCKOCD155KO spleen stimulator cells. One hundred percent of such T-hybridomas recognized an
MHC-independent surface ligand as they reacted against MHCKO stimulators, while some frequency of T-hybridomas in each fusion were CD155-specific as they
were unreactive against MHCKOCD155KO stimulators. **p < 0.01; *p < 0.5; NS, not significant.
LNT cells from each mouse strain. We found that all T-
hybridomas from CD155+/+ and CD155−/− QB mice expressed
MHC-independent TCRs that reacted against MHCKO spleen
APC stimulators (Figure 1C left), and that a subset of these
expressed CD155-specific TCRs that failed to react against
MHCKOCD155−/− APCs (Figure 1C right). Strikingly, ∼4%
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of T-hybridomas from CD155-sufficient LNT cells were
CD155-reactive, whereas none (0%) of the T-hybridomas from
CD155-deficient LNT cells were CD155-reactive (p < 0.05)
(Figure 1C right). Thus CD155-specific TCRs are not generated
with LNT cells from CD155-deficient mice, indicating that
in vivo CD155 expression is required for positive selection of
CD155-specific MHC-independent TCRs.
Identification of CD102 and CD48 as
MHC-Independent TCR Ligands
We then wished to determine if the requirement for in vivo
ligand expression is limited only to TCRs specific for CD155
or if it extends to TCRs specific for other MHC-independent
ligands as well. However, no other MHC-independent TCR
ligands have yet been identified. Consequently, we embarked
on identifying the MHC-independent ligands recognized by
the three T-hybridomas that we had selected to study. We
first verified that all three T-hybridomas reacted against ligands
expressed on the murine CH27 B cell line but did not react to
ligands expressed on the human 293T cell line (Figure 1A). We
then transfected a cDNA library made from stimulatory CH27
cells into non-stimulatory human 293T cells and performed
limiting dilution cDNA expression cloning (11) (Figure S2). In
this way, we ultimately identified three cDNA clones whose
transfection into 293T cells converted them into stimulatory cells
for each T-hybridoma.We determined that the transfected cDNA
stimulating T-hyb 146 encoded ICAM-2 (CD102); the transfected
cDNA stimulating T-hyb 38 encoded CD48; and the transfected
cDNA stimulating T-hyb 25 encoded CD155.
To verify their ligand specificities, we stimulated each T-
hybridoma with human 293T cells that had been transfected with
known cDNAs encoding CD102, CD48, and CD155 (Figure 2A).
Indeed, T-hyb 146 reacted only against 293T cells transfected
with CD102 cDNA and its reactivity was blocked only by anti-
CD102 monoclonal antibody (mAb); T-hyb 38 reacted only
against 293T cells transfected with CD48 cDNA and its reactivity
was blocked only by anti-CD48 mAb; and T-hyb 25 reacted only
against 293T cells transfected with murine CD155 (Figure 2A).
For T-hyb 25, we performed domain-swapping between human
and murine CD155 to map the CD155 epitope recognized
by TCR-25 (Figure S3) and found that stimulation of T-hyb
25 requires that all 3 external CD155 domains be murine
(not human) sequences, indicating that TCR-25 recognizes a
novel epitope formed by all three external domains of murine
CD155 that has not been previously described (11) (Figure S3).
Thus, TCR-146 recognizes ICAM-2 (CD102), TCR-38 recognizes
CD48, and TCR-25 recognizes a unique CD155 epitope.
To determine if there might be additional stimulatory ligands
for each T-hybridoma, we assessed the ability of ligand-specific
mAbs to block each T-hybridoma’s reactivity against murine
CH27 stimulator B-cells (Figure 2B). While conventionally
MHC-restricted TCR responses are never blocked by anti-ligand
antibodies, MHC-independent TCR responses are blocked by
anti-ligand mAbs (11). Interestingly, we found that the reactivity
of T-hyb 146 is blocked by anti-CD102; that of T-hyb 38 is
blocked by anti-CD48; and that of T-hyb 25 is blocked by
anti-CD155 (Figure 2B). Thus, we have identified novel MHC-
independent TCRs with specificity for two novel ligands (CD102
and CD48) and a novel epitope on CD155.
MHC-Independent TCRs Recognize Native
Ligands Without Antigen Processing
Because antibodies bind to conformational epitopes on native
proteins, blockade of T-hybridoma reactivity by ligand-specific
antibodies suggests that theirMHC-independent TCRs recognize
native protein ligands. Consequently, we might be able
to stimulate these T-hybridomas with recombinant proteins
immobilized on plastic in the absence of APCs. Indeed T-hyb 146
specifically responds to plate-bound recombinant CD102 protein
but not to recombinant CD155 (control) protein, while T-hyb
25 reacts to plate-bound CD155 protein but not CD102 protein
(Figure 3A). Moreover, the response of each T-hybridoma to its
plate-bound protein ligand is blocked by mAb specific for that
protein ligand (Figure 3A).
Interestingly, the stimulatory ligand for each of these T-
hybridomas (i.e. CD102, CD48, and CD155) is an adhesion
molecule that can also bind with low affinity to counter-receptors
on lymphocytes, as ICAM-2 (CD102) binds to LFA-1 and Mac-
1 (17, 18); CD48 binds to CD2 and 2B4 (19); and CD155
binds to CD226, CD96, TIGIT, vitronectin, and CD113 (20, 21).
Even though adhesive interactions are low affinity, we wanted to
verify that the specific reactivity of each T-hybridoma is signaled
by its clonotypic TCR rather than by its adhesive counter-
receptor. To do so, we stimulated T-hybridomas with 293T
cell transfectants and assessed the ability of soluble anti-CD3ε
mAb to inhibit the transduction of ligand-specific responses
(Figure 3B). As a positive control for anti-CD3ε inhibition of
TCR responses, we included a responder cell line (4G4) that was
retrovirally transduced to express the CD155-specific A11 TCR
reported previously (11) (Figure 3B). Indeed, responses of the
three T-hybridomas and the A11 TCR-transduced 4G4 cell line
to ligand-transfected 293T stimulator cells is blocked by soluble
anti-CD3ε mAb, indicating that each response is transduced
by CD3-dependent TCR components. We conclude that the
reactivity of T-hybridomas is signaled by surface TCR complexes.
To determine the ligand binding affinity of one of these
TCRs, we produced soluble TCR-146 and measured its binding
to recombinant ICAM-2 (CD102) by surface plasmon resonance
(SPR) in a completely cell-free assay (Figure 3C). The soluble
TCR-146 binds to immobilized murine CD102 with dissociation
constant KD of 1.6µM and 0.5µM, derived from equilibrium
and kinetic fittings, respectively. No detectable binding of TCR-
146 was observed to immobilized human CD102 under the same
condition (Figure 3C). The kinetic association and dissociation
rates, kon and koff, are 1.15 × 10
4 (1/Ms) and 5.12 × 10−3
(1/s), respectively, for TCR-146/mCD102 binding (Table 1).
Compared to the ligand binding affinity of conventional (MHC-
restricted) αβTCRs, ligand binding by the MHC-independent
TCR-146 displayed relatively high ligand binding affinity. In
addition, both of their kinetic rate constants, especially koff, are
substantially slower than those of conventional MHC-restricted
TCR-ligand interactions. Although the kon is 3–5 fold slower,
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FIGURE 2 | Identification of MHC-independent ligands for TCRs 25, 38, and 146. (A) IL-2 production by T hybridomas 25, 38, and 146 after 16 h stimulation with 1 ×
105 293T cells transfected with the indicated cDNAs. Where indicated, blocking mAbs (10µg/ml) were added at the beginning of cell culture. (B) IL-2 production by
hybridomas after 16 h stimulation with 1 × 104 CH27 cells in the presence or absence of blocking mAbs. Data are representative of three independent experiments.
****p < 0.0001; ***p < 0.001; **p < 0.01.
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FIGURE 3 | T-hybridomas recognize and react to recombinant protein ligands immobilized on plastic. (A) Responses of T-hybridomas (1 × 105) to immobilized
(10µg/ml) protein in the presence or absence of blocking antibodies. Responses of T-hyb 146 and T-hyb 25 against CD102 and CD155, respectively, were each set
at 100%. Each data point represents the mean ± SEM of triplicate experiments. (B) Responses of T-hyb 146, 38, 25, and TCR-transduced 4G4 cells (TCR A11)
against 293T cells transfected with their respective ligand-encoding cDNA in the presence or absence of blocking anti-CD3ε mAb (clone 7D6, 10µg/ml). (C) Binding
of soluble TCR 146 to recombinant CD102. Surface plasmon resonance (SPR) measurements of binding between solubilized TCR 146 αβTCRs heterodimers and
immobilized recombinant murine CD102 (left panel) or human CD102 (right panel). The analytes consisted of serial dilutions of soluble αβTCR heterodimers ranging
from 0.5 to 8µM. The dissociation constants were obtained by kinetic curve fitting via BIAevaluation. Data are representative of two independent experiments.
****p < 0.0001; **p < 0.01.
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TCR146 mICAM2 0.55 ± 0.25 5.12 ± 2.38 × 10−3 1.15 ± 0.95 × 104
TCRA11 mCD155 0.26 ± 0.99 4.13 ± 0.91 × 10−3 1.72 ± 0.47 × 104
TCRB12A mCD155 0.23 ± 0.08 4.08 ± 1.34 × 10−3 1.96 ± 0.91 × 104
the dissociation rate koff for TCR146/mCD102 binding is 10–
100 times slower than that of conventional MHC-restricted
TCRs (22, 23). Similar slow on and off rates were also observed
for ligand binding by two previously reported CD155-specific
MHC-independent TCRs (A11 and B12A) (11) (see Table 1).
Indeed, the slower on and off kinetic binding rate constant
resemble many antibody-antigen interactions (24). Thus, MHC-
independent TCR-146 binds with high affinity to an epitope on
native murine ICAM-2 (CD102).
TCR-146 Recognizes ICAM-2 Protein
Independently of LFA-1
In addition to being the stimulatory ligand for TCR-146, ICAM-
2 (CD102) is also a low affinity ligand for the adhesion
molecule LFA-1 which consists of a dimer composed of CD11a
and CD18 chains on endothelial cells, monocytes, platelets
and lymphocytes. The cellular adhesion molecule LFA-1 binds
to several adhesive ligands (including ICAM-1, ICAM-2, and
ICAM-3) (25–27) to promote cell-cell interactions which can
be blocked by anti-LFA-1 mAb. We then assessed anti-LFA-1
blockade of each of the three T-hybridomas against their specific
ligands (Figure 4). Interestingly, we found that anti-LFA-1 mAb
non-specifically blocks all three T-hybridoma responses against
cell-bound ligands but fails to block stimulation of these same T-
hybridomas by plate-bound ligands–even when the plate-bound
ligand is ICAM-2 (CD102) which is itself a ligand for LFA-1
(Figures 4A–C and Figure S4). Thus, LFA-1 promotes ligand-
nonspecific adhesion between T-hybridomas and stimulator cells
that is necessary for cell-bound TCRs to subsequently engage
their cell-bound ligands, but LFA-1 is not required for TCRs
to engage any cell-free ligands–including recombinant ICAM-
2 (CD102) for which TCR-146 has higher binding affinity than
LFA-1 (28).
MHC-Independent Thymic Selection of
TCR-146
To examine positive selection in the thymus, we constructed
a hCD2-driven transgene with TCR-146 (TCR-146Tg) that
is specific for a novel MHC-independent ligand (Figure 5A)
and we introduced TCR-146Tg into Rag2KOBcl-2Tg host mice
(Figures 5B–G). To assess if MHC and coreceptor expression,
or lack thereof, affected TCR-146 signaling of positive selection,
we systematically analyzed thymic selection signaling by TCR-
146 in: (i) QuadKORag2KOBcl-2Tg host mice that were both
MHC-deficient and coreceptor-deficient (Figures 5B,C), (ii)
MHCKORag2KOBcl-2Tg host mice that were MHC-deficient
but coreceptor-sufficient (Figures 5D,E), and (iii) Rag2KOBcl-
2Tg host mice that were both MHC-sufficient and coreceptor-
sufficient (Figures 5F,G).
TCR-146 effectively signals QuadKORag2KOBcl-2Tg
thymocytes to undergo positive selection as revealed by
thymocyte upregulation of CD5, CD69, and CCR7 and as
revealed by generation of peripheral LNT cells (Figures 5B,C).
Thus, unlike conventional MHC-restricted TCRs whose
signaling of positive selection requires both MHC and CD4/CD8
coreceptor expression, TCR-146 signaling of positive selection
requires neither MHC nor coreceptor expression.
Because hCD2-driven TCR transgenes are prematurely
expressed in DN thymocytes before CD4/CD8 coreceptors are
expressed, we thought that TCR-146 might access coreceptor-
free Lck and signal MHC-independent positive selection in
thymocytes at the DN stage of differentiation even in coreceptor-
sufficient MHCKO mice (12). In fact, TCR-146 did signal
MHCKORag2KO thymocytes to undergo positive selection and to
generate large numbers of peripheral LNT cells (Figures 5D,E).
To assess TCR-146 signaling of positive selection in mice
that are MHC-sufficient and coreceptor-sufficient, we introduced
TCR-146Tg into Rag2KOBcl-2Tg mice. We found that TCR-
146 does signal Rag2KOBcl-2Tg thymocytes to undergo positive
selection and to generate large numbers of peripheral LNT cells
(Figures 5F,G), presumably because TCR-146 signaling occurs
before thymocytes developmentally express coreceptor proteins
on their cell surfaces. Taken together, all of the results in
Figure 5 document that TCR-146 signaling of positive selection
is coreceptor-independent and MHC-independent.
ICAM-2 (CD102) Is the Required Thymic
Selecting Ligand for TCR-146
We then considered if TCR-146 must encounter its high affinity
ligand ICAM-2 to signal positive selection. To assess this
possibility, we introduced TCR146Tg into Rag2KOBcl-2Tg mice
that are either CD102WT and express ICAM-2, or are CD102KO
and lack ICAM-2 (Figure 6A). Importantly, we found that
positive selection signaling by TCR-146 does strictly require
ICAM-2, as TCR-146 does not signal positive selection and does
not generate peripheral LNT cells in ICAM2-deficient CD102KO
mice (Figures 6A,B). Thus, TCR-146 strictly requires ICAM-2 to
signal positive selection in the thymus.
However, it is possible that ICAM-2 might only promote
ligand-non-specific LFA-1/ICAM-2 adhesive interactions needed
for TCR-146 to engage other unknown positive selecting ligands
in the thymus. Consequently, we compared TCR-146Tg mediated
positive selection in mice that are either LFA-1-deficient or
ICAM-2-deficient (Figures 6C,D). We observed that TCR-146Tg
mediated positive selection is completely abrogated in ICAM-
2-deficient (CD102KO) host mice but proceeds successfully in
LFA-1-deficient (CD11aKO) host mice as determined both by
thymocyte expression markers (CD5, CD69, CCR7) and by LNT
cell generation (Figures 6C,D). Indeed, the number of TCR-
146Tg LNT cells in CD11aKOCD102WT mice (∼20–25 × 106)
is unaffected by LFA1-deficiency (compare CD102WT mice in
Figures 6B,D), even though LFA-1 deficiency non-specifically
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FIGURE 4 | TCR-146 and TCR-25 require LFA-1-dependent interactions for cell-to-cell dependent stimulation. (A) Responses of T-hyb 146, (B) T-hyb 38, and (C)
T-hyb 25 against CH27 stimulator cells or plate-bound recombinant proteins in the presence or absence of blocking antibodies. T-hyb responses in the absence of
blocking antibodies were set at 100%. Each data point represents the mean ± SEM of triplicate experiments. **p < 0.01; *p < 0.05; NS, not significant.
reduces LNT cell numbers in polyclonal CD11aKO mice
(Figure S5) (29). We conclude that ICAM-2 is the required
positively selecting ligand for TCR-146 and that high affinity
ligands are required for MHC-independent TCRs to signal
positive selection in the thymus.
TCR-146 Positive Selection Does Not
Require Bcl-2Tg Expression
We thought that TCR-146 engagement of its high affinity ligand
ICAM-2 in the thymus might signal in vivo clonal deletion
which was prevented in mice expressing the pro-survival Bcl-
2Tg. Surprisingly, however, positively selected CCR7+ TCR-
146 thymocytes appear in both Bcl-2Tg+ and Bcl-2Tg− mice
(Figure 6E) and differentiate into peripheral TCR-146 LNT cells
in both Bcl-2Tg+ and Bcl-2Tg− mice, albeit in lower (but still
substantial) numbers in Bcl-2Tg− mice (Figure 6F). Thus, despite
engaging their high affinity ICAM-2 ligand in the thymus,
many TCR-146 thymocytes survive thymic selection in Bcl-
2Tg− mice and differentiate into mature peripheral T cells,
indicating that clonal deletion is incomplete (Figure 6F). We
suggest that clonal deletion is incomplete because coreceptor-
free Lck (which is the only Lck available to MHC-independent
TCRs) transduces intracellular TCR signals so inefficiently
that even high affinity TCR-ligand interactions fail to activate
sufficient Lck to signal all TCR-146 thymocytes to undergo
clonal deletion.
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FIGURE 5 | Thymic selection of transgenic TCR-146 requires neither MHC nor CD4/CD8 coreceptors. (A) hCD2-driven TCR-146 transgenic constructs encoding
TCRα and TCRβ chains. (B,D,F) Thymocyte profiles from host transgenic mice expressing transgenic TCR-146. Numbers in TCRβ and CD5 histograms indicate
Mean Fluorescence Intensity (MFI). Numbers in CD69 and CCR7 histograms indicate frequency of positive cells. Thymus cellularity is shown as mean ± SE (n = 3–9
mice/group). (C,E,G) Numbers of LN αβT cells in TCR transgenic mice (mean ± SE, n = 3–9 mice/group). ****p < 0.0001.
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FIGURE 6 | ICAM-2 (CD102) is the thymic selecting ligand for TCR-146. (A) In vivo positive selection signaled by TCR-146 requires ICAM-2 (CD102) expression.
Numbers in CD5 histograms indicate MFI. Numbers in CD69 and CCR7 histograms indicate frequency of positive cells. Thymus cellularity is shown as mean ± SE of
6–10 mice/group. (B) Numbers of LN αβT cells in TCR transgenic mice (mean ± SE, n = 6–10 mice/group). (C,D) LFA-1 (CD11a expression) is not required for
TCR146 signaling of positive selection in vivo. (C) Thymocyte profiles and (D) LN αβT cell numbers from transgenic mice represent the mean ± SE of 6–9 mice/group.
(E,F) Comparison of thymocytes profiles and αβ LNT cell numbers in different Bcl-2Tg+ and Bcl-2Tg− mouse strains expressing the TCR-146 transgene. ****p <
0.0001; ***p < 0.001; **p < 0.01.
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The MHC-Independent TCR Repertoire Is
Self-Reactive
If coreceptor-free Lck is unable to efficiently signal clonal
deletion, then self-reactivity might be a general feature of MHC-
independent TCR repertoires in both Bcl-2Tg+ and Bcl-2Tg−
mice. To assess this possibility, we examined the reactivity of
primary LNT cells from Bcl-2Tg+ and Bcl-2Tg− mice against
self and third-party spleen stimulator cells (T-depleted, LPS
stimulated, irradiated spleen cells) in in vitro mixed lymphocyte
responses as measured by CFSE dye dilution (Figure 7A).
Interestingly, regardless of the presence or absence of Bcl-2Tg
expression, QuadKO T cells are self-reactive as they react against
syngeneic (QuadKO) stimulator cells as well as against third
party B6 and B10.A spleen stimulator cells (Figure 7A). In
contrast, neither B6 nor B6.Bcl-2Tg T cells are self-reactive as
they are unreactive against syngeneic (B6) spleen stimulator cells
(Figure 7A). Thus, the MHC-independent TCR repertoire in
QuadKO mice is self-reactive in both the presence and absence
of in vivo Bcl-2Tg, consistent with our concept that coreceptor-
free Lck is too inefficient in transducing high affinity TCR signals
to effectively delete autoreactive thymocytes and prevent their
appearance in the periphery.
Limited Diversity of the Peripheral
Polyclonal MHC-Independent TCR
Repertoire
Affinity is a measure of how well-receptor and ligand fit together,
with low affinity indicating a poor fit and high affinity indicating
a near-perfect fit. Because many different receptor structures
would create a poor fit, many different TCR sequences might
bind a ligand with low affinity; whereas few receptor structures
would create a near-perfect fit and bind a ligand with high
affinity. Similarly, low affinity positive selection would signal
many different TCRs and generate a highly diverse receptor
repertoire, whereas high affinity positive selection would signal
few different TCRs and generate a receptor repertoire of limited
diversity. This reasoning predicts that the receptor diversity of
peripheral MHC-restricted TCRs would greatly exceed that of
peripheral MHC-independent TCR repertoires.
To evaluate this prediction, we compared the diversity of
TCRα and TCRβ sequence repertoires from the periphery of
MHC-restricted B6, B10.BR, BALB/c, and B6.Bcl2 mice vs.
TCRα and TCRβ sequence repertoires from the periphery of
MHC-independent QuadKO (Q) and QB mice as quantified by
the Inverse Simpson Index (ISI) (Figure 7B and Figure S6).
Note that the greater the ISI value, the greater the diversity
of sequences within a TCR repertoire. Remarkably, we found
that overall TCRα and TCRβ sequence diversities of peripheral
MHC-independent TCRs are dramatically lower than those of
MHC-restricted TCRs (Figure 7B and Figure S6). On average
overall, the sequences of MHC-independent TCR repertoires
are 10–50 fold less diverse that those of MHC-restricted TCRs.
Figure 7B summarizes overall TCRα and TCRβ clonal diversity
in eachmouse strain examined, without accounting for variations
in V-gene usage. Figure S6 displays TCRα and TCRβ clonal
diversity among each individual V-gene in the mouse strains
examined, and reveals that the repertoire diversity of MHC-
restricted TCRs in B6 mice is far greater than the repertoire
diversity of MHC-independent TCRs in QuadKO mice (p <
10−15), and the repertoire diversity of MHC-restricted TCR in
B6.Bcl-2Tg mice is far greater than the repertoire diversity of
MHC-independent TCRs in QB mice (p < 10−12 to 10−15).
Based on these findings, we conclude that positive selection
by high affinity TCR-ligand engagements severely reduces TCR
repertoire diversity and increases self-reactivity.
DISCUSSION
The present study reveals that MHC-independent TCRs require
high affinity TCR-ligand engagements to signal positive selection
and that high affinity positive selection generates a mature
repertoire with increased self-reactivity and markedly reduced
TCR diversity. In this study we first identified novel MHC-
independent TCRs in QuadKO mice that were reactive against
three native self-proteins which otherwise functioned as low
affinity cell adhesion molecules. We focused on TCR-146 which
was reactive against ICAM-2 (CD102), a low affinity ligand for
the cell adhesion molecule LFA-1, and which bound soluble
ICAM-2 (CD102) independently of LFA-1 with relatively high
1.6µM affinity. To assess in vivo positive selection signaling by
TCR-146, we constructed TCR-146 transgenic mice and found
that TCR-146 strictly required its high affinity ligand ICAM-2 to
signal positive selection in the thymus, demonstrating that high
affinity positive selection signaling was not unique to CD155-
specific TCRs (12) but was in fact a general feature of MHC-
independent TCRs. Moreover, we discovered that high affinity
positive selection signaling in QuadKO mice selected polyclonal
TCRs that were self-reactive and, most surprisingly, with very
limited repertoire diversity. Thus, this study indicates that the
affinity of TCR-ligand engagements required to signal positive
selection in the thymus affects, inversely, the diversity and self-
tolerance of the mature TCR repertoire.
The requirement for high affinity TCR-ligand engagements to
signal positive selection is unique to MHC-independent TCRs
as MHC-restricted TCRs signal positive selection by engaging
very low affinity ligands. The obvious difference in TCR-ligand
affinities required to signal positive selection of immature
thymocytes is quite surprising because positive selection requires
uniquely weak TCR signals–and this should be the case regardless
of ligand specificity. While TCR signal strength is often equated
with TCR-ligand affinity, this study requires that TCR signal
strength and TCR affinity be conceptually separated. When
this is done, the positive selection requirement for weak
TCR signaling means that only few activated p56Lck (Lck)
tyrosine kinase molecules must be recruited to ligand-engaged
surface TCR complexes. So the different TCR affinities required
by MHC-restricted and MHC-independent TCRs to signal
positive selection reflect the different efficiencies with which
Lck is recruited to different ligand-engaged TCR complexes.
In CD4/CD8 coreceptor-sufficient mice, Lck is associated with
the cytosolic tails of CD4/CD8 coreceptors that bind to
surface pMHC ligands together with MHC-restricted TCRs,
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FIGURE 7 | Increased TCR self-reactivity and diminished TCR repertoire diversity in polyclonal MHC-independent αβT cell populations. (A) T cell proliferative
responses were measured by CFSE dye dilution of primary LN αβT cells from the indicated mice against various spleen cell stimulators. (B) TCR repertoire sequence
diversities as measured by the Inverse Simpson Index of all TCRα sequences (left panel) and all TCRβ sequences (right panel) in the indicated mouse strains. P-values
are shown of ISI diversity values between B6 and QuadKO (Q) mice and between B6.Bcl-2Tg and QB mice.
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so that coreceptors efficiently bring Lck to ligand-engaged
TCRs. In contrast, in CD4/CD8 coreceptor-deficient mice,
Lck is coreceptor-free and must be passively captured within
surface TCR clusters, a process which is highly inefficient and
requires high affinity TCR-ligand engagements that persist long
enough to passively capture free Lck within TCR-ligand clusters.
Thus, the weak TCR signals that induce positive selection are
generated either by low affinity coreceptor-dependent TCR-
ligand engagements or by high affinity coreceptor-independent
TCR-ligand engagements, with the former generating an MHC-
restricted TCR repertoire and the latter generating an MHC-
independent TCR repertoire.
The requirement for high affinity TCR-ligand engagements
to signal positive selection profoundly effects the self-reactivity
and diversity of the mature TCR repertoire. Regarding the self-
reactivity of the mature TCR repertoire, high affinity positive
selection necessarily generates a peripheral MHC-independent
TCR repertoire with high affinity for self-protein ligands. Even
so, it is surprising thatMHC-independent TCRs are incompletely
self-tolerant to their own self-proteins as revealed by their
self-reactivity in mixed lymphocyte cultures in vitro. Indeed,
their self-reactivity is not limited to in vitro assays as MHC-
independent QuadKO mice have in vivo lymphocytic infiltrations
into multiple organs beginning at ∼6 months of age (10). As
explanation, we think that MHC-independent TCRs with high
affinity for self-ligands are not fully deleted in the QuadKO
thymus because free Lck is so inefficient at transducing TCR
signals that high affinity TCR-ligand interactions fail to signal
strongly enough to induce clonal deletion. While high affinity
MHC-independent TCRs that avoided clonal deletion in QuadKO
mice might have been expected to become T-regulatory cells,
we found that T-regulatory cells account for only ∼5% of
peripheral T cells in QuadKO mice (unpublished). Instead, we
think that peripheral MHC-independent T cells become self-
reactive in the periphery because mature T cells increase their
intra-cellular content of Lck during their differentiation from
immature thymocytes which generates stronger TCR signals in
the periphery.
Failure of high affinity MHC-independent TCRs to induce
clonal deletion can provide insight into how much CD4/CD8
co-receptors contribute to the strength of intracellular signal
transduction during thymic selection. In our thinking negative
selection in the thymus requires that sufficient Lck be recruited to
ligand-engaged TCR complexes to transduce strong intracellular
signals that induce immature thymocyte death. In the absence of
CD4/CD8 coreceptors, recruitment of coreceptor-independent
Lck to ligand-engaged TCRs is inefficient and requires long
duration TCR binding to the negatively selecting ligand as best
measured by dwell time (30). In contrast, CD4/CD8 coreceptors
efficiently bring Lck to ligand-engaged TCRs which consequently
require much shorter duration TCR binding to the negatively
selecting ligand. In fact, the dwell time of the high affinity
OT-I MHC class I-restricted TCR on its negatively selecting
pMHC ligand was determined to be ∼ 0.2–1 s (30), with similar
dwell times subsequently determined for other MHC-restricted
TCRs (23). In marked contrast to the short ligand dwell times
of MHC-restricted TCRs, the dwell time of MHC-independent
TCR-146 on its thymic selecting ligand ICAM-2 is ∼130 s which
is 100–200 times greater, with similarly long dwell times of
168–170 s for the binding of two previously reported MHC-
independent TCRs, A11 and B12A (11, 31), to their CD155
ligand. We suggest that the much shorter dwell times required
of MHC-restricted than MHC-independent TCRs reveal the
major contribution of CD4/CD8 coreceptors to the strength of
intracellular signal transductions required for clonal deletion
in the thymus. Notably, while a few MHC-restricted TCRs
on peripheral T cells can signal independently of CD4/CD8
coreceptors, that is not true for thymic selection of those same
TCRs which is strictly coreceptor-dependent in the thymus
because Lck in immature DP thymocytes is all coreceptor-
bound (32–34). Moreover, concordant with our concept that
TCR-specific clonal deletion cannot be efficiently transduced in
thymocytes by coreceptor-free Lck, we previously showed that
T cells bearing self-reactive MHC-independent TCRs were not
deleted in mice whose thymocytes normally expressed MHC and
CD4/CD8 coreceptors but contained re-engineered coreceptor-
free Lck that was unable to bind to CD4/CD8 coreceptors (12).
Regarding the limited repertoire diversity of MHC-
independent TCRs, we think limited diversity is a necessary
outcome of the positive selection requirement for high affinity
TCR engagements. Because affinity is a measure of how well-
receptor and ligand fit together with high affinity indicating
a near-perfect fit, a high affinity requirement for positive
selection limits positive selection signaling to only the few
MHC-independent TCRs able to bind an individual ligand with
sufficient affinity to signal positive selection. In contrast, a low
affinity positive selection requirement allows many different
poorly fitting TCRs to engage an individual ligand and signal
positive selection. As a result, a high affinity positive selection
requirement severely limits the number of different TCRs
that can be selected into the mature repertoire by an individual
self-ligand in the thymus, whereas a low affinity positive selection
requirement allows multiple, even millions, of different TCRs
to be selected into the mature repertoire by an individual
self-ligand in the thymus (35). An important implication of this
reasoning concerns TCR reactivity to foreign ligands. Because
all peripheral TCRs are originally selected by self-ligands in
the thymus, TCR recognition of foreign ligands is entirely the
result of fortuitous cross-reactivities. Consequently, peripheral
TCR repertoires with limited diversity are far less likely to
fortuitously recognize and react against a foreign pathogenic
ligand. Consequently, the peripheral MHC-independent TCR
repertoire is likely to be deficient in recognizing and reacting to
foreign pathogenic ligands.
Based on this study, we suggest that MHC-restricted TCRs
with low affinity positive selection requirements arose as a
result of evolutionary pressure to generate a maximally diverse
and, therefore maximally protective, TCR repertoire. Selection
of a highly diverse and more self-tolerant TCR repertoire was
achieved during evolution by employing CD4/CD8 coreceptors
with cytosolic tails that bound Lck and extracellular domains
that bound to MHC, since CD4/CD8 coreceptors efficiently
recruited Lck to MHC-engaged TCRs which markedly lowered
the affinity of TCR-ligand engagements required to signal positive
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selection in the thymus. Notably, since CD4 and CD8 coreceptor
external domains only bind to different classes of MHC proteins,
the involvement of CD4 and CD8 coreceptors in thymic
selection necessarily resulted in low affinity positive selection
of a peripheral TCR repertoire that was MHC-restricted, highly
diverse, and self-tolerant.
It is a curious feature of the MHC-independent TCR
repertoire that the ligands identified so far are involved in cell
adhesion. We suspect this is because cell adhesion ligands are
highly expressed on cells in the thymus which is necessary
for sufficient numbers of TCR-ligand engagements to form
and signal positive selection. In addition, we previously noted
that cell adhesion molecules like CD155 are downregulated
during T-hybridoma fusions which decreases the fratricide of T-
hybridomas that bear TCRs with those ligand specificities and
increases their relative recovery in T-hybridoma fusions (36).
Finally, naturally arising MHC-independent TCRs
generated by Rag-mediated gene rearrangements resemble
re-engineered therapeutic CAR T cells in recognizing self-
ligands independently of MHC (37, 38). They differ from
re-engineered CARs in consisting of normal αβTCR chains
which transduce signals in the same way as conventional
αβTCRs and differently than CAR T cells. Consequently, we
think naturally arising MHC-independent αβTCRs with MHC-
independent specificity for tumor antigens may possibly prove
to be of greater therapeutic usefulness than CARs.
In conclusion, this study provides novel insights into
the relationship between the required affinity of TCR-ligand
engagements that signal positive selection in the thymus and
critical features of the mature TCR repertoire in the periphery.
This study suggests the novel concept that the required affinity of
positive selection signaling in the thymus determines, inversely,




deficient (Rag2−/−), Quad-deficient (B2m−/−H-2-
Ab1−/−Cd4−/−Cd8a−/−) (10), and Quad-deficient.Bcl2 mice
containing the hBcl2 transgene (39) were bred in our own animal
colony. Mice deficient in CD155 (Cd155−/−) were generated as
previously described (21), as were ICAM-2 (Cd102−/−) deficient
mice (40) and LFA-1 (Cd11a−/−) (18). Animal care was in
accordance with National Institutes of Health (NIH) guidelines.
New transgenic mouse strains constructed for this study were
generated by cloning full length TCR cDNAs for TCRα and
TCRβ into the human CD2 transgenic vector to obtain T cell
specific expression.
Generation of T Cell Hybridomas
Lymph node αβT (LNT) cells from QuadKO and QuadKOBcl-2Tg
(QB) mice were stimulated with plate-bound anti-TCRβ/CD28
(5 and 2µg/ml) for 48 hr. fused to TCR-null BW5147 cells, and
subcloned at <1 cell/well (10). IL-2 secretion was measured by
enzyme-linked immunosorbent assays (ELISA) (R&D Systems)
after overnight stimulation. Hybridomas were screened for TCR
reactivity (using plate-bound anti-TCR antibodies) as well as
reactivity against LPS activated- MHC- and CD155-deficient
splenic B cells and the murine B lymphoma CH27 cells (41).
Antibodies and Reagents
MAbs with the following specificities were used in the present
study: CD4 (GK1.5 or RM4.4), TCRβ (H57-957), CD5 (53-
7.3), CD8α (53-6.7), CD69 (H1.2F3), CCR7 (4B12) were
obtained from BD Biosciences (San Jose, CA). LEAF-purified
antibodies against mouse CD155 (clone 4.24.1) were obtained
from Biolegend. Functional grade antibodies against mouse
CD102 (clone 3C4 (mIC2/4), mouse CD54 (clone YN1/1.7.4),
mouse CD11a (LFA-1 alpha, clone M17/4) were obtained from
eBiosciences, mouse CD48 (clone HM48-1) was obtained from
Biolegend. Purified anti-CD3 antibodies [clone 7D6 (42)] were
generated in house.
Stimulation With Plate-Bound Ligands
Flat-bottom 96-well plates were coated overnight with
recombinant proteins in 50 µl of PBS. Hybridomas were
added overnight, after which supernatants were assessed for IL-2.
Construction and Screening of the cDNA
Library
Total RNA was prepared from the murine CH27 cell line by
RNeasy Maxi (QIAGEN Inc.) and was purified with FastTrack
MAG Maxi mRNA isolation kit (Invitrogen) to obtain poly(A)+
RNA. cDNA was synthesized with the SuperScript system
(Invitrogen) and was cloned into SPORT6 vector with SalI
and NotI restriction sites. ElectroMAX DH10B competent cells
(Invitrogen) were transformed by electroporation, and after
titration, E. coli (∼150 clones/well) were inoculated overnight
into 96-well format culture blocks (10 blocks). Plasmids were
purified with a Qiaprep 96 Turbo miniprep kit (QIAGEN) and
were transfected to HEK293T cells with Lipofectamine 2000
(Invitrogen) in 96-well flat-bottom plates and left overnight.
Hybridomas were cocultured with cDNA-transfected 293T cells
for 24 h, after which mIL-2 amounts in the supernatants
were obtained. Positive clones were selected for secondary
and tertiary screenings. Subpool libraries (∼20 clones/well, 48
wells) and clone libraries (1 clone/well, 96 wells) were prepared
and screened. Positive clones were sequenced to identify the
specificity of the transfected cDNA.
Flow Cytometry
Cells from thymi and lymph nodes were analyzed on an LSRII
(BD Biosciences) and dead cells were excluded by forward light-
scatter and propidium-iodide uptake.
Generation of Soluble αβTCR Heterodimers
DNA encoding extracellular portions of TCR α and β chains
were cloned into pET30a vectors as described (11). Receptors
were expressed as inclusion bodies in BL21 (DE3) cells.
Functional and soluble TCR heterodimers were produced
by a rapid dilution refolding procedure as previously
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described (43). Refolded TCR heterodimers were purified
using anion exchange chromatography followed by size
exclusion chromatography.
Surface Plasmon Resonance
Surface plasmon resonance measurements were performed using
a BIAcore 3000 instrument and analyzed with BIAevaluation 4.1
software (Biacore AB). Murine ICAM-2-Fc, human ICAM-2-Fc
and NKp44-Fc fusion proteins (R&D systems) were immobilized
on carboxylated dextran CM3 chips (Biacore AB) to 4000–7000
response units (RU) using a primary amine-coupling in 10mM
sodium acetate (pH 5.0). The analytes consisted of serial dilutions
of TCR-146 between 8 and 0.5µM in a buffer containing
10mMHepes (pH7.4), 0.15MNaCl, 1mMCaCl2 and 0.5 mg/ml
BSA. The dissociation constants were obtained by kinetic curve
fitting for the binding of TCR146 to murine ICAM-2 using
BIAevaluation 4.1 (BIAcore Inc.).
T Cell Proliferation
To test T cell reactivity against stimulator cells from different
mouse strains, we labeled purified LNT responder cells with
CFSE and cocultured them with irradiated (2000 rads) LPS-
activated splenic B cell blasts. Cultures were analyzed on day 4
by multicolor flow cytometry.
Epitope Mapping
Chimeric CD155 molecules were generated as described (11).
Briefly, chimeric CD155 molecules between mouse and human
were generated. The chimeric constructs were synthesized
(GenScript) and cloned into pIRES2-ZsGeen1 expression vector
(Clontech). Hybridoma cells were cocultured with 293T cells
transfected with chimeric cDNA for 24 hr after which
supernatant IL-2 was measured.
Analysis of T Cell Repertoire Sequence
Diversity
TCRα and β repertoire sequences for all indicated mouse
strains were obtained by high throughput next generation
RNA sequencing through Adaptive Biotechnologies Corp. and
iRepertoire, Inc. Three or more animals from each strain were
sequenced. Sequence diversity was estimated for each overall
repertoire and for each individual Vα- and Vβ-gene family using
Inverse Simpson Index (ISI) as calculated by AAfrequency, an
in-house developed program (8).
DATA AVAILABILITY STATEMENT
TCRβ sequences used for diversity analysis are available through
Adaptive Biotechnology’s ImmuneAccess database [https://
clients.adaptivebiotech.com/pub/lu-2019-natcomms] with
doi: 10.21417/JL2019. Both TCRα and TCRβ sequences are also
available upon request.
ETHICS STATEMENT
The animal study was reviewed and approved by NCI Animal
Care and Use Committee.
AUTHOR CONTRIBUTIONS
FV, IS, PS, and AS conceptualized and designed the study
and interpreted the results. FV performed the experiments,
analyzed data, and drafted the manuscript. IS, JL, AB, XT, TG,
AA, MR, and JA performed experiments and contributed to
the analysis of the data. KH, JY, and PS provided conceptual
and technical support. BE provided an experimental animal
model. AS conceived and supervised the research program and
experiments, and wrote the manuscript. All authors listed have
approved the work for publication.
FUNDING
The funding of this work is provided by the Intramural Research
Program (IRP) of the US National Institutes of Health, National
Cancer Institute, Center for Cancer Research and the National
Institute of Allergy and Infectious Diseases (NIAID).
ACKNOWLEDGMENTS
We thank Drs. Dinah Singer, Naomi Taylor, Motoko Kimura,
Yousuke Takahama and Hyun Park for commenting on
the manuscript.
SUPPLEMENTARY MATERIAL




1. Hesslein DG, Schatz DG. Factors and forces controlling V(D)J recombination.
Adv Immunol. (2001) 78:169–232. doi: 10.1016/S0065-2776(01)
78004-2
2. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition.
Nature. (1988) 334:395–402. doi: 10.1038/334395a0
3. Allen PM. Peptides in positive and negative selection: a delicate balance. Cell.
(1994) 76:593–6. doi: 10.1016/0092-8674(94)90497-9
4. Starr TK, Jameson SC, Hogquist KA. Positive and negative
selection of T cells. Annu Rev Immunol. (2003) 21:139–76.
doi: 10.1146/annurev.immunol.21.120601.141107
5. Brzostek JN, Gascoigne RJ. Thymic origins of t cell receptor alloreactivity.
Transplantation. (2017) 101:1535–41. doi: 10.1097/TP.0000000000001654
6. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J. Understanding
the drivers of MHC restriction of T cell receptors. Nat Rev Immunol. (2018)
18:467–78. doi: 10.1038/s41577-018-0007-5
7. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs,
peptides, and coreceptors. Annu Rev Immunol. (2006) 24:419–66.
doi: 10.1146/annurev.immunol.23.021704.115658
8. Lu J, Van Laethem F, Bhattacharya A, Craveiro M, Saba I, Chu J, et al.
Molecular constraints on CDR3 for thymic selection of MHC-restricted
TCRs from a random pre-selection repertoire. Nat Commun. (2019) 10:1019.
doi: 10.1038/s41467-019-08906-7
Frontiers in Immunology | www.frontiersin.org 15 June 2020 | Volume 11 | Article 1216
Van Laethem et al. Selection of MHC-Independent TCRs
9. Van Laethem F, Tikhonova AN, Singer A. MHC restriction is imposed on
a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during
thymic selection. Trends Immunol. (2012) 33:437–41. doi: 10.1016/j.it.2012.
05.006
10. Van Laethem F, Sarafova SD, Park JH, Tai X, Pobezinsky L, Guinter TI, et al.
Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT
cells that recognize antigens independently of the MH. Immunity. (2007)
27:735–50. doi: 10.1016/j.immuni.2007.10.007
11. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C,
et al. alphabeta T cell receptors that do not undergo major histocompatibility
complex-specific thymic selection possess antibody-like recognition
specificities. Immunity. (2012) 36:79–91. doi: 10.1016/j.immuni.2011.11.013
12. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le
Saout C, et al. Lck availability during thymic selection determines the
recognition specificity of the T cell repertoire. Cell. (2013) 154:1326–41.
doi: 10.1016/j.cell.2013.08.009
13. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell
repertoire. Nature. (1999) 402:255–62. doi: 10.1038/46218
14. Moran AE, Hogquist KA. T-cell receptor affinity in thymic development.
Immunology. (2012) 135:261–7. doi: 10.1111/j.1365-2567.2011.03547.x
15. Morris GP, Allen PM. How the TCR balances sensitivity and specificity
for the recognition of self and pathogens. Nat Immunol. (2012) 13:121–8.
doi: 10.1038/ni.2190
16. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum
L, et al. Clonal deletion and the fate of autoreactive thymocytes that
survive negative selection. Nat Immunol. (2012) 13:569–78. doi: 10.1038/n
i.2292
17. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization
of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med.
(1991) 174:253–67. doi: 10.1084/jem.174.1.253
18. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, et al. Relative
contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J
Immunol. (1999) 163:5029–38.
19. McArdel SL, Terhorst C, Sharpe AH. Roles of CD48 in regulating
immunity and tolerance. Clin Immunol. (2016) 164:10–20.
doi: 10.1016/j.clim.2016.01.008
20. Gao J, Zheng Q, Xin N, Wang W, Zhao C. CD155, an onco-
immunologic molecule in human tumors. Cancer Sci. (2017) 108:1934–38.
doi: 10.1111/cas.13324
21. Maier MK, Seth S, Czeloth N, Qiu Q, Ravens I, Kremmer E, et al. The
adhesion receptor CD155 determines the magnitude of humoral immune
responses against orally ingested antigens. Eur J Immunol. (2007) 37:2214–25.
doi: 10.1002/eji.200737072
22. Huseby ES, Crawford F, White J, Marrack P, Kappler JW. Interface-disrupting
amino acids establish specificity between T cell receptors and complexes
of major histocompatibility complex and peptide. Nat Immunol. (2006)
7:1191–9. doi: 10.1038/ni1401
23. Adams JJ, Narayanan S, Birnbaum ME, Sidhu SS, Blevins SJ, Gee MH,
et al. Structural interplay between germline interactions and adaptive
recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.
Nat Immunol. (2016) 17:87–94. doi: 10.1038/ni.3310
24. Katsamba PS, Navratilova I, Calderon-Cacia M, Fan L, Thornton K, Zhu
M, et al. Kinetic analysis of a high-affinity antibody/antigen interaction
performed by multiple biacore users. Anal Biochem. (2006) 352:208–21.
doi: 10.1016/j.ab.2006.01.034
25. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient
interactions and cell locomotion. Ann Rev Immunol. (1991) 9:27–66.
doi: 10.1146/annurev.iy.09.040191.000331
26. Springer TA, DustinML. Integrin inside-out signaling and the immunological
synapse. Curr Opin Cell Biol. (2012) 24:107–15. doi: 10.1016/j.ceb.2011.1
0.004
27. Xu H, Tong IL, De Fougerolles AR, Springer TA. Isolation, characterization,
and expression of mouse ICAM-2 complementary and genomic DNA. J
Immunol. (1992) 149:2650–5.
28. Schurpf T, Springer TA. Regulation of integrin affinity on cell surfaces. EMBO
J. (2011) 30:4712–27. doi: 10.1038/emboj.2011.333
29. Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJ, Duncan
G, et al. LFA-1-deficient mice show normal CTL responses to virus
but fail to reject immunogenic tumor. J Exp Med. (1996) 183:1415–26.
doi: 10.1084/jem.183.4.1415
30. Stepanek O, Prabhakar AS, Osswald C, King CG, Bulek A, Naeher D, et al.
Coreceptor scanning by the T cell receptor provides a mechanism for T cell
tolerance. Cell. (2014) 159:333–45. doi: 10.1016/j.cell.2014.08.042
31. Lu J, Van Laethem F, Saba I, Chu J, Tikhonova AN, Bhattacharya A, et al.
Structure of MHC-Independent TCRs and their recognition of native antigen
CD155. J Immunol. (2020) 204:3351–59. doi: 10.4049/jimmunol.1901084
32. Wiest DL, Ashe JM, Abe R, Bolen JB, Singer A. TCR activation of ZAP70
is impaired in CD4+CD8+ thymocytes as a consequence of intrathymic
interactions that diminish available p56lck. Immunity. (1996) 4:495–504.
doi: 10.1016/S1074-7613(00)80415-X
33. Kerry SE, Buslepp J, Cramer LA, Maile R, Hensley LL, Nielsen AI, et al.
Interplay between TCR affinity and necessity of coreceptor ligation: high-
affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
J Immunol. (2003) 171:4493–503. doi: 10.4049/jimmunol.171.9.4493
34. Vidal K, Daniel C, Hill M, Littman DR, Allen PM. Differential requirements
for CD4 in TCR-ligand interactions. J Immunol. (1999) 163:4811–8.
35. Wang B, Primeau TM, Myers N, Rohrs HW, Gross ML, Lybarger L, et al. A
single peptide-MHC complex positively selects a diverse and specific CD8T
cell repertoire. Science. (2009) 326:871–4. doi: 10.1126/science.1177627
36. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri
F, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates
activation-induced apoptosis in T-cell hybridomas. Nature. (1995) 373:441–4.
doi: 10.1038/373441a0
37. June CH, SadelainM. Chimeric antigen receptor therapy.NEngl JMed. (2018)
379:64–73. doi: 10.1056/NEJMra1706169
38. June CH, O’Connor RS, Kawalekar OU, Ghassemi S, Milone MC. CAR
T cell immunotherapy for human cancer. Science. (2018) 359:1361–65.
doi: 10.1126/science.aar6711
39. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell
cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad
Sci USA. (1996) 93:9545–52. doi: 10.1073/pnas.93.18.9545
40. Gerwin N, Gonzalo JA, Lloyd C, Coyle AJ, Reiss Y, Banu N, et al. Prolonged
eosinophil accumulation in allergic lung interstitium of ICAM-2 deficient
mice results in extended hyperresponsiveness. Immunity. (1999) 10:9–19.
doi: 10.1016/S1074-7613(00)80002-3
41. Haughton G, Arnold LW, Bishop GA, Mercolino TJ. The CH series of murine
B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol
Rev. (1986) 93:35–51. doi: 10.1111/j.1600-065X.1986.tb01501.x
42. Coulie PG, Uyttenhove C, Wauters P, Manolios N, Klausner RD, Samelson
LE, et al. Identification of a murine monoclonal antibody specific for an
allotypic determinant on mouse CD3. Eur J Immunol. (1991) 21:1703–9.
doi: 10.1002/eji.1830210718
43. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J.
Specificity on a knife-edge: the alphabeta T cell receptor. Curr Opin Struct
Biol. (2006) 16:787–95. doi: 10.1016/j.sbi.2006.09.004
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Van Laethem, Saba, Lu, Bhattacharya, Tai, Guinter, Engelhardt,
Alag, Rojano, Ashe, Hanada, Yang, Sun and Singer. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 16 June 2020 | Volume 11 | Article 1216
